Drug – bio-affecting and body treating compositions – Lymphokine
Patent
1989-10-06
1993-04-06
Draper, Garnette D.
Drug, bio-affecting and body treating compositions
Lymphokine
514 12, 530351, 930144, A61K 3702
Patent
active
052001768
ABSTRACT:
Methods suitable for the protection, inhibition and prevention the deleterious effects of reactive oxygen species are provided, wherein an effective amount of a tumor necrosis factor is administered. Pretreatment of tissues and organs to be transplanted is described. Perfusion solutions and the preparation of perfused, excised tissue are described.
REFERENCES:
patent: 4808402 (1989-02-01), Leibovich et al.
patent: 4846782 (1989-07-01), Bonnem
patent: 4861587 (1989-10-01), Urbascheb et al.
patent: 4985241 (1991-01-01), Zimmerman et al.
Neta J. Immunol 140(1) 108-111 (1988).
Urbascheck et al. Lymphokene Res. 6(3) 179-186 (1987).
Neta Blood 72(3) 1093-1095 (1988).
Tsujimoto et al. Biochem. Biophys. Res. Commun. 137(3) 1094-1100 (1986).
Hellqvist et al., Dialog Information Services, file 155, Medline 66-91, Dialog accession No. 06998107.
Zimmerman et al., Dialog Information Services, file 155, Medline 66-91, Dialog accession No. 06866198.
Shalaby et al., Leuk. Biol. 41:196-204 (1987).
Wong, et al., Science 242:941-944 (1988).
Sugarman, B. J. et al., Science 230:943-945 (1985).
Carswell, E. A. et al., Proc. Natl. Acad. Sci. USA, 72:3666-3670 (1975).
Jacob, C. O. & McDevitt, H. O., Nature, 331:356-358 (1988).
Schutze et al., J. Immunol., 140:3000-3005 (1988).
Maessen et al., Transplantation Proc., 21(1):1261-1262 (1989).
Walton, P. E. & Cronin, M. J., Endocrinology, 125(2):925-929 (1989).
Gordon et al., J. Appl. Physiol., 64:1688 (1988).
Sullivan et al., Infection & Immunity, 56(7):1722-1729 (1988).
Holtzmann et al., J. Immunol 139(4):1161-1167 (1987).
Cross et al., J. Exper. Med., 169:2021-2027 (1989).
Wallach et a., J. Immunol., 132:2464 (1984).
Hahn et al. Proc. Natl. Acad. Sci. USA, 82:3814 (1985).
Tiegs et al., Biochem. Pharmacol., 38:627 (1989).
White et al., J. Clin. Invest., 79:1868 (1987).
Urbaschek, et al, Lymphokine Res. 6(3):179-186 (1987).
Slordal, et al., Eur J. Haematol 43:428-434 (1989).
Neta et al., Fed. Proc. 46(4):1200 (abstract) (1987).
Neta et al., J. Immunol. 136(7):2483-2485 (1986).
Neta et al. Pharmac. Ther. 39:261-266 (1988).
Neta et al., Lymphokine Res. 5(1):S105-S110 (1986).
Clark, A. and Chaudhri, G., J. of Cellular Biochem., UCLA Symposia on Molecular and Cellular Biology, Supplement 12a:B023 (1988).
Matsubara et al., J. Immunol. 137:3295-3298 (1986).
Leurs et al., Biochemistry International 18(2):295-299 (1989).
Hjalmarsson et al., Proc. Natl. Acad. Sci. USA 84:6340 (1987).
Saez et al., Proc. Natl. Acad. Sci. USA, 84:3056 (1987).
Oda et al., Science 244:974-976 (1989).
Omar et al., Cancer Res. 47:3473 (1987).
Taylor et al., Brain Res., 347:268 (1985).
Braquet et al., Int. Arch Allergy Appl. Immunol. 88:88-100 (1989).
Galaris et al., Biochem. Biophys. Res. Comm., 160(3):1162-1168 (1989).
Kalayoglu et al., The Lancet, Mar. 19, 1988, pp. 617-619.
Palladino et al., Int. J. Radiat Biol., 41:183-91 (1982).
Omar, B. A. and McCord, J. M., Free Radical Biology & Medicine, 9:473-478 (1990).
Omar, B. A. et al., Free Radical Biology & Medicine, 9:465-471 (1990).
Decker, T. and Lohmann-Matthes, M-L., J. of Immunol. Methods, 15:61-69 (1988).
Berkow et al. J. Immunol 139(11)3783-3791 (1987).
Goeddel David V.
Wong Grace H. W.
Adler Carolyn R.
Draper Garnette D.
Genentech Inc.
Guest Shelly J.
LandOfFree
Method for protection of ischemic tissues using tumor nerosis fa does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for protection of ischemic tissues using tumor nerosis fa, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for protection of ischemic tissues using tumor nerosis fa will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-534701